{
  "symbol": "ACIU",
  "company_name": "AC Immune S.A.",
  "ir_website": "https://ir.acimmune.com/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Press Releases",
          "url": "https://ir.acimmune.com/news",
          "content": "[Skip to content](#lfg-main-content)\n\n#  Press Releases \n\n## PRESS RELEASES\n\nYear None2024202320222021202020192018201720162015201420132012201120102009200820062005\n\n2024\n\nDate | Title | View  \n---|---|---  \nNov 14, 2024  |  [AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease](/news-releases/news-release-details/ac-immune-reports-positive-interim-results-phase-2-trial-aci) |  [](https://ir.acimmune.com/static-files/a24c8419-3d32-4732-81db-1fbce7af79e4 \"20241114-aciu-vacsyn-interim-final-clean.pdf\")  \nNov 13, 2024  |  [AC Immune to Present at the Jefferies 2024 London Healthcare Conference](/news-releases/news-release-details/ac-immune-present-jefferies-2024-london-healthcare-conference) |  [](https://ir.acimmune.com/static-files/a9409017-7db9-42d4-bb08-49f29878508d \"20241113-aciu-jefferies-curtain-raiser.pdf\")  \nNov 05, 2024  |  [AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update](/news-releases/news-release-details/ac-immune-reports-third-quarter-2024-financial-results-and) |  [](https://ir.acimmune.com/static-files/e51739cc-5855-4ced-8c31-b20f2cbb8485 \"20241105__ACIU 3Q24 Earnings FINAL.pdf\")  \nSep 17, 2024  |  [AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease](/news-releases/news-release-details/ac-immune-receives-second-milestone-payment-following-progress) |  [](https://ir.acimmune.com/static-files/177989a1-412f-4473-bdea-56e0ca7b7160 \"20240917-aciu-retain-milestone-final.pdf\")  \nAug 28, 2024  |  [AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions](/news-releases/news-release-details/ac-immunes-pi-2620-tau-pet-diagnostic-phase-3-receives-fast) |  [](https://ir.acimmune.com/static-files/ec8257a6-8ff8-4dd5-9b47-46bfac810d36 \"20240828-aciu-pi-2620-fasttrack-final-clean.pdf\")  \nAug 06, 2024  |  [AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update](/news-releases/news-release-details/ac-immune-reports-second-quarter-2024-financial-results-and) |  [](/node/11376/pdf)  \nJul 31, 2024  |  [AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024](/news-releases/news-release-details/ac-immune-unveils-novel-therapeutic-antibody-drug-conjugate-adc) |  [](https://ir.acimmune.com/static-files/2cfe7569-a248-4bfa-9d87-7fd9e18d5e13 \"20240731-aciu-aaic24-moradc-final.pdf\")  \nJul 25, 2024  |  [AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease](/news-releases/news-release-details/ac-immunes-aci-35030-now-jnj-2056-granted-fda-fast-track) |  [](https://ir.acimmune.com/static-files/3845c155-bb27-428b-8bfb-031769107723 \"20240725-aciu-aci-35-030-fasttrack-final.pdf\")  \nJul 16, 2024  |  [AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024](/news-releases/news-release-details/ac-immune-showcasing-its-novel-morphomer-antibody-drug-conjugate) |  [](/node/11326/pdf)  \nMay 28, 2024  |  [AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024](/news-releases/news-release-details/ac-immune-present-jefferies-global-healthcare-conference-june) |  [](https://ir.acimmune.com/static-files/529d20bd-c243-4804-b888-fec84502c619 \"20240528-aciu-jefferies-conference-june-2024-curtain-raiser.pdf\")\n"
        }
      ]
    },
    {
      "section_name": "In the News",
      "links": [
        {
          "title": "In the News",
          "url": "https://ir.acimmune.com/in-the-news",
          "content": "[Skip to content](#lfg-main-content)\n\n#  In the News \n\n## IN THE NEWS\n\nYear None2023202220212020201920182016\n\nNone\n\n![logo](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2023/05/10/5-38-29/logo.jpg?itok=UBLw9QcO)\n\n[ May 10, 2023  Alzheimer-Hoffnung  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/alzheimer-hoffnung)\n\n![Michael J. Fox Foundation Newsletter ](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2022/10/25/5-31-58/MJFF_logo.png?itok=lVo1pYTP)\n\n[ Oct 25, 2022  The Image Worth a Decade of Scientific Resolve  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/image-worth-decade-scientific-resolve)\n\n![Kooperationen für gelungene Medikamentenentwicklung](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2022/10/25/5-48-09/B%C3%B6Z-logo.png?itok=5ryadZYE)\n\n[ Oct 23, 2022  Kooperationen für gelungene Medikamentenentwicklung  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/kooperationen-fur-gelungene-medikamentenentwicklung)\n\n![« Il n’est pas possible de soigner alzheimer »](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2022/06/07/11-08-21/Le-temps-vector-Logo.jpg?itok=qLiRSg8W)\n\n[ Jun 07, 2022  « Il n’est pas possible de soigner alzheimer »  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/il-nest-pas-possible-de-soigner-alzheimer)\n\n![TheInnovator_logo](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2022/06/03/12-44-10/TheInnovatorNews_Logo.jpg?itok=vbtcIK42)\n\n[ Jun 03, 2022  The Innovator - AC Immune’s Quest To Make Alzheimer’s Disease Preventable  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/innovator-news-ac-immunes-quest-make-alzheimers-disease)\n\n![Focus Logo](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2022/06/01/13-46-45/FOCUS-Logo.png?itok=r_1mjJ7l)\n\n[ Jun 01, 2022  FOCUS - Im Interview mit Dr. Kurt-Martin Mayer  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/focus-im-interview-mit-dr-kurt-martin-mayer)\n\n![BUNTE - Wir haben bei Parkinson endlich einen Durchbruch erzielt](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2022/06/09/4-49-03/Bunte_logo.jpg?itok=EqGJltEG)\n\n[ May 19, 2022  BUNTE - Wir haben bei Parkinson endlich einen Durchbruch erzielt  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/bunte-wir-haben-bei-parkinson-endlich-einen-durchbruch-erzielt)\n\n![Logo](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2022/04/12/12-33-28/FOCUS-Logo.png?itok=pQf70MI2)\n\n[ Apr 09, 2022  FOCUS - Parkinson früher erkennen  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/focus-parkinson-fruher-erkennen)\n\n![Logo](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2022/03/31/4-03-35/Logo%20-%20BioCentury.JPG?itok=bqIW5tcK)\n\n[ Mar 31, 2022  AC Immune clears first hurdle for α-synuclein PET tracer  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/ac-immune-clears-first-hurdle-synuclein-pet-tracer)\n\n![NZZ](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/news/2022/03/28/11-23-17/NZZ_Logo.jpg?itok=VSMC2wOq)\n\n[ Mar 28, 2022  Frauen der Wirtschaft - Prof. Andrea Pfeifer im Interview mit der NZZ  ![Right arrow](/sites/g/files/knoqqb83461/themes/site/nir_pid1707/client/images/arrows-right-small-light.png) ](/news-releases/news-release-details/prof-andrea-pfeifer-will-mit-ihrer-firma-eine-stille-pandemie)\n\n  * 1\n\n\n\n## Press Releases\n\n[Read More](/news)\n\n![events and presentations](/system/files-encrypted/nasdaq_kms/inline-images/Events%20%26%20presentations_4_0.jpg)\n\n## Events & Presentations\n\n[Read More](/events-and-presentation)\n"
        }
      ]
    },
    {
      "section_name": "Events & Presentations",
      "links": [
        {
          "title": "Events & Presentations",
          "url": "https://ir.acimmune.com/events-and-presentation",
          "content": "![logo]()\n\n[](https://www.cookiebot.com/en/what-is-behind-powered-by-cookiebot/)\n\n  * [Consent](#)\n  * [Details](#)\n  * [[#IABV2SETTINGS#]](#)\n  * [About](#)\n\n\n\n## This website uses cookies\n\nWe use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. \n\nConsent Selection\n\n**Necessary**\n\n**Preferences**\n\n**Statistics**\n\n**Marketing**\n\n[Show details](#)\n\n  * Necessary  9\n\nNecessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.\n\n    * [Cookiebot2](#)[Learn more about this provider![]()](https://www.cookiebot.com/goto/privacy-policy/ \"Cookiebot's privacy policy\")\n\n**1.gif** Used to count the number of sessions to the website, necessary for optimizing CMP product delivery. \n\n**Maximum Storage Duration** : Session**Type** : Pixel Tracker\n\n**CookieConsent** Stores the user's cookie consent state for the current domain\n\n**Maximum Storage Duration** : 1 year**Type** : HTTP Cookie\n\n    * [Google6](#)[Learn more about this provider![]()](https://business.safety.google/privacy/ \"Google's privacy policy\")\n\nSome of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness.\n\n**_GRECAPTCHA** This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.\n\n**Maximum Storage Duration** : 180 days**Type** : HTTP Cookie\n\n**_grecaptcha** This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**rc::a** This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**rc::b** This cookie is used to distinguish between humans and bots. \n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**rc::c** This cookie is used to distinguish between humans and bots. \n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**rc::f** This cookie is used to distinguish between humans and bots. \n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n    * [chimpstatic.com1](#)\n\n**ak_bmsc** This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.\n\n**Maximum Storage Duration** : 1 day**Type** : HTTP Cookie\n\n  * Preferences  0\n\nPreference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.\n\nWe do not use cookies of this type.\n\n  * Statistics  0\n\nStatistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.\n\nWe do not use cookies of this type.\n\n  * Marketing  21\n\nMarketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.\n\n    * [Google3](#)[Learn more about this provider![]()](https://business.safety.google/privacy/ \"Google's privacy policy\")\n\nSome of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness.\n\n**_ga** Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels.\n\n**Maximum Storage Duration** : 2 years**Type** : HTTP Cookie\n\n**_ga_#** Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels.\n\n**Maximum Storage Duration** : 2 years**Type** : HTTP Cookie\n\n**NID** Pending\n\n**Maximum Storage Duration** : 6 months**Type** : HTTP Cookie\n\n    * [YouTube18](#)[Learn more about this provider![]()](https://business.safety.google/privacy/ \"YouTube's privacy policy\")\n\n**#-#** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**iU5q-!O9@$** Registers a unique ID to keep statistics of what videos from YouTube the user has seen.\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**LAST_RESULT_ENTRY_KEY** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Session**Type** : HTTP Cookie\n\n**LogsDatabaseV2:V#||LogsRequestsStore** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Persistent**Type** : IndexedDB\n\n**remote_sid** Necessary for the implementation and functionality of YouTube video-content on the website. \n\n**Maximum Storage Duration** : Session**Type** : HTTP Cookie\n\n**ServiceWorkerLogsDatabase#SWHealthLog** Necessary for the implementation and functionality of YouTube video-content on the website. \n\n**Maximum Storage Duration** : Persistent**Type** : IndexedDB\n\n**TESTCOOKIESENABLED** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : 1 day**Type** : HTTP Cookie\n\n**VISITOR_INFO1_LIVE** Pending\n\n**Maximum Storage Duration** : 180 days**Type** : HTTP Cookie\n\n**YSC** Pending\n\n**Maximum Storage Duration** : Session**Type** : HTTP Cookie\n\n**ytidb::LAST_RESULT_ENTRY_KEY** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**YtIdbMeta#databases** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Persistent**Type** : IndexedDB\n\n**yt-remote-cast-available** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**yt-remote-cast-installed** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**yt-remote-connected-devices** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**yt-remote-device-id** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**yt-remote-fast-check-period** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**yt-remote-session-app** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**yt-remote-session-name** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n  * Unclassified 0\n\nUnclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.\n\nWe do not use cookies of this type.\n\n\n\n\n[Cross-domain consent2](#) Your consent applies to the following domains:\n\nList of domains your consent applies to:\n\n[ir.acimmune.com](https://ir.acimmune.com)\n[ www.acimmune.com](https://www.acimmune.com)\n\nCookie declaration last updated on 9/17/24 by [Cookiebot](https://www.cookiebot.com \"Cookiebot\")\n\n## [#IABV2_TITLE#]\n\n[#IABV2_BODY_INTRO#]\n\n[#IABV2_BODY_LEGITIMATE_INTEREST_INTRO#]\n\n[#IABV2_BODY_PREFERENCE_INTRO#]\n\n[#IABV2_LABEL_PURPOSES#]\n\n[#IABV2_BODY_PURPOSES_INTRO#]\n\n[#IABV2_BODY_PURPOSES#]\n\n[#IABV2_LABEL_FEATURES#]\n\n[#IABV2_BODY_FEATURES_INTRO#]\n\n[#IABV2_BODY_FEATURES#]\n\n[#IABV2_LABEL_PARTNERS#]\n\n[#IABV2_BODY_PARTNERS_INTRO#]\n\n[#IABV2_BODY_PARTNERS#]\n\nCookies are small text files that can be used by websites to make a user's experience more efficient.The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission.This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.You can at any time change or withdraw your consent from the Cookie Declaration on our website.Learn more about who we are, how you can contact us and how we process personal data in our [Privacy Policy](https://www.acimmune.com/privacy-policy/).Please state your consent ID and date when you contact us regarding your consent.\n\n**Do not sell or share my personal information**\n\nDeny Allow selection Customize Allow all\n\n[Skip to content](#lfg-main-content)\n\n#  Events & Presentations \n\nPresentations \n\n### Investor Presentation\n\n[Download PDF](/static-files/8b1a972a-9d38-4a93-871c-ea51ec37a564)\n\n## Search\n\nUpcoming Events \n\nMore events are coming soon. \n\nPast Events \n\n[Jefferies 2024 London Healthcare Conference](/events/event-details/jefferies-2024-london-healthcare-conference)\n\nNov 20, 2024 at 6:00 AM EST \n\n[Annual General Meeting 2024](/events/event-details/annual-general-meeting-2024)\n\nJun 20, 2024 at 2:30 PM CEST \n\n[Jefferies 2024 Global Healthcare Conference](/events/event-details/jefferies-2024-global-healthcare-conference)\n\nJun 5, 2024 at 3:30 PM EDT \n\n[AC Immune SA Conference Call & Webcast](/events/event-details/ac-immune-sa-conference-call-webcast)\n\nMay 13, 2024 at 2:30 PM CEST \n\n[AD/PD™ 2024 Symposium](/events/event-details/adpdtm-2024-symposium)\n\nMar 6, 2024 from 8:40 AM to 10:40 AM WET \n\n[Jefferies 2023 London Healthcare Conference](/events/event-details/jefferies-2023-london-healthcare-conference)\n\nNov 16, 2023 at 6:30 AM EST \n\n[KOL Webinar On Amyloid Plaque PET Imaging In Alzheimer’s Disease As A Surrogate Of Clinical Efficacy](/events/event-details/kol-webinar-amyloid-plaque-pet-imaging-alzheimers-disease-surrogate-clinical)\n\nNov 9, 2023 at 10:00 AM EST \n\n[Jefferies 2023 CNS & Neuro Summit](/events/event-details/jefferies-2023-cns-neuro-summit)\n\nOct 12, 2023 at 8:00 AM EDT \n\n[H.C. Wainwright 25th Annual Global Investment Conference](/events/event-details/hc-wainwright-25th-annual-global-investment-conference)\n\nSep 11, 2023 at 7:00 AM EDT \n\n[BTIG Virtual Biotechnology Conference 2023](/events/event-details/btig-virtual-biotechnology-conference-2023)\n\nAug 8, 2023 at 9:30 AM EDT \n\n![Cookiebot session tracker icon loaded](https://imgsct.cookiebot.com/1.gif?dgi=857167d5-6649-4f3a-abdf-c97811a740d2)\n"
        }
      ]
    },
    {
      "section_name": "Financial Reporting",
      "links": [
        {
          "title": "Financial Reporting",
          "url": "https://ir.acimmune.com/sec-filings",
          "content": "[Skip to content](#lfg-main-content)\n\n#  SEC Filings \n\n## SEC Filings\n\nGroup 3,4,5Annual FilingsCurrent ReportsMergers & AcquisitionsOtherProxy FilingsQuarterly FilingsRegistration Statements\n\nFiling year - Any -2024202320222021202020192018201720162015\n\n- Any -\n\n[Filing date ](?items_per_page=10&order=field_nir_sec_date_filed&sort=asc \"sort by Filing date\") | [Description](?items_per_page=10&order=field_nir_sec_description&sort=asc \"sort by Description\") | [Form](?items_per_page=10&order=field_nir_sec_form&sort=asc \"sort by Form\") | Filing Group | View  \n---|---|---|---|---  \nNov 14, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-016272) |  Current Reports |  [0000950103-24-016272.rtf](/static-files/985524be-292b-4b74-bd73-a736b90d2dda) [0000950103-24-016272.xls](/static-files/ef307e69-4a42-4cb4-bf92-f20e40f71fdd) [0000950103-24-016272.pdf](/static-files/4b85919c-ed47-43f3-9566-091753518a68)  \nNov 14, 2024 | An amendment to the SC 13G filing | [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0000921895-24-002730) |  Other |  [0000921895-24-002730.rtf](/static-files/b760d336-9fc9-4209-98b0-63d6e2e792e6) [0000921895-24-002730.xls](/static-files/4812a535-53b2-46d0-a6dd-e89ea675ea3b) [0000921895-24-002730.pdf](/static-files/41a2b5a4-7561-4514-9ff5-3c0d3317cbe3)  \nNov 05, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0001558370-24-014326) |  Current Reports |  [0001558370-24-014326.rtf](/static-files/664be402-a871-48c6-8e9a-5fd6d0d61338) [0001558370-24-014326.xls](/static-files/0ee1e184-f896-4255-b379-c9458041fd28) [0001558370-24-014326.pdf](/static-files/f9caacb3-c43d-47cc-abfa-96442badc244)  \nSep 27, 2024 | Filed by \"insiders\" prior intended sale of restricted stock. Non-EDGAR filing | [144](/sec-filings/sec-filing/144/0001950047-24-007431) |  Other |  [0001950047-24-007431.rtf](/static-files/6bc081ac-7bce-4d13-9432-4d82369f67c7) [0001950047-24-007431.xls](/static-files/78a2274c-b8ac-41cd-ade8-eec3d2eb03d8) [0001950047-24-007431.pdf](/static-files/92e193ec-47de-4340-9d68-74bd627ec6ff)  \nSep 19, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-013746) |  Current Reports |  [0000950103-24-013746.rtf](/static-files/8b0f709d-1046-4b40-981b-cadca42738a6) [0000950103-24-013746.xls](/static-files/f3fe5fc1-3638-4ada-9e7c-e6089954ecad) [0000950103-24-013746.pdf](/static-files/c0b61c8f-c01c-48a5-bc2c-7e1a9d073203)  \nSep 18, 2024 | Filed by \"insiders\" prior intended sale of restricted stock. Non-EDGAR filing | [144](/sec-filings/sec-filing/144/0001950047-24-007232) |  Other |  [0001950047-24-007232.rtf](/static-files/eccd8b18-2c73-49d4-a70b-57a078b73c17) [0001950047-24-007232.pdf](/static-files/f4e405de-dc9b-4ef6-ab04-e57c47d4df25)  \nSep 17, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-013644) |  Current Reports |  [0000950103-24-013644.rtf](/static-files/714ac0f6-a0a8-4419-b27c-7035ede9fe9a) [0000950103-24-013644.xls](/static-files/b117008a-5f0c-4945-b4ef-2f14ec1caf84) [0000950103-24-013644.pdf](/static-files/1e2103af-5cf1-46b8-91f0-b64f25add1c9)  \nAug 28, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-012695) |  Current Reports |  [0000950103-24-012695.rtf](/static-files/afc29f08-6c47-4582-b13c-59edd0c833ed) [0000950103-24-012695.xls](/static-files/c7bd34e4-2f71-4983-b141-036bb8777020) [0000950103-24-012695.pdf](/static-files/09c753ec-10d6-40d3-9ffd-81236058bcab)  \nAug 06, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0001558370-24-010944) |  Current Reports |  [0001558370-24-010944.rtf](/static-files/4907e279-a033-431d-84ba-93fcd2d81e24) [0001558370-24-010944.xls](/static-files/0b6c963e-2a98-4c41-85af-c168bd8845d8) [0001558370-24-010944.pdf](/static-files/375b17e3-5860-4d31-8e6e-50f7f50855ac) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/6-k/0001558370-24-010944)  \nAug 06, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-011753) |  Current Reports |  [0000950103-24-011753.rtf](/static-files/c9280967-4542-46c6-b65c-85726650b743) [0000950103-24-011753.xls](/static-files/b4c8e1f4-cade-4a96-8052-4528f9d76d48) [0000950103-24-011753.pdf](/static-files/e6ecd531-025c-4fd7-820b-0baf25498ef5)  \nAug 06, 2024 | Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 | [424B5](/sec-filings/sec-filing/424b5/0000950103-24-011782) |  Registration Statements |  [0000950103-24-011782.rtf](/static-files/95980596-9726-4384-8567-8954cd906725) [0000950103-24-011782.xls](/static-files/a5156fbf-22d2-4e2d-be56-ad84cc6fb62d) [0000950103-24-011782.pdf](/static-files/d1845c5b-6525-4cd4-b925-b22e01715e63)  \nJul 31, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-011251) |  Current Reports |  [0000950103-24-011251.rtf](/static-files/32ec2513-e786-4dd2-bd5a-fea6131ea888) [0000950103-24-011251.xls](/static-files/a0dc975a-02f6-40b0-95dc-3e8c86eeb238) [0000950103-24-011251.pdf](/static-files/9ef29636-0f21-46e7-a375-2a29d26513a5)  \nJul 31, 2024 | EFFECT | [EFFECT](/sec-filings/sec-filing/effect/9999999995-24-002330) |  Other |  [9999999995-24-002330.rtf](/static-files/9642b102-d46f-4461-b78b-37d907c00b90) [9999999995-24-002330.xls](/static-files/66963f44-29fd-4d40-be45-80739c4b0bd2) [9999999995-24-002330.pdf](/static-files/9739ad4a-3d0c-43b1-8f09-e66d550c5ffb)  \nJul 29, 2024 | CORRESP | [CORRESP](/sec-filings/sec-filing/corresp/0000950103-24-010979) |  Other |  [0000950103-24-010979.rtf](/static-files/3e2aeb10-5de4-4a75-9b8f-d878ba256b63) [0000950103-24-010979.xls](/static-files/a13e79bd-1c0c-4bea-b974-e2bfc509ebe1) [0000950103-24-010979.pdf](/static-files/d19b1825-75e8-422f-ad8f-0891194aa62d)  \nJul 26, 2024 | Amendment to a previously filed F-3 | [F-3/A](/sec-filings/sec-filing/f-3a/0000950103-24-010895) |  Registration Statements |  [0000950103-24-010895.rtf](/static-files/114bbe95-2e42-4c19-83fb-6b8f6dd774fd) [0000950103-24-010895.xls](/static-files/0e89d72d-170f-4a2a-8d57-4a12ad7904c2) [0000950103-24-010895.pdf](/static-files/a620e21e-2e60-475b-b62d-790da796f0c6)  \nJul 25, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-010718) |  Current Reports |  [0000950103-24-010718.rtf](/static-files/850c9f96-be0d-477f-b0fe-7e273846b464) [0000950103-24-010718.xls](/static-files/8e56abe7-6192-4d10-9522-26a81b3a7db3) [0000950103-24-010718.pdf](/static-files/f4f069d4-031d-4ed4-916c-860f61f7b427)  \nJun 20, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-008566) |  Current Reports |  [0000950103-24-008566.rtf](/static-files/413df07b-c267-4104-b806-2774fd532458) [0000950103-24-008566.xls](/static-files/ad1a7474-c0eb-4f99-aa03-29aad7fab746) [0000950103-24-008566.pdf](/static-files/84b6c0d0-8b1a-41da-9596-74fd0610b516)  \nMay 21, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-006931) |  Current Reports |  [0000950103-24-006931.rtf](/static-files/77f59e81-8d8d-48c3-a81e-4435bc7b0a70) [0000950103-24-006931.xls](/static-files/67684e09-ad05-4cc3-82d7-764555aa3474) [0000950103-24-006931.pdf](/static-files/8e9f589f-10ef-403e-bed7-1dd23a1075b5)  \nMay 16, 2024 | Filed by \"insiders\" prior intended sale of restricted stock. Non-EDGAR filing | [144](/sec-filings/sec-filing/144/0001965301-24-000070) |  Other |  [0001965301-24-000070.rtf](/static-files/289a1547-883d-45fd-8aeb-82e6f6033bdf) [0001965301-24-000070.pdf](/static-files/ed4072ed-1185-44e4-a0a4-896a49c0c636)  \nMay 13, 2024 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | [6-K](/sec-filings/sec-filing/6-k/0000950103-24-006573) |  Current Reports |  [0000950103-24-006573.rtf](/static-files/f3a7b9c1-4086-4105-baea-0eb84d719417) [0000950103-24-006573.xls](/static-files/d9f6da59-2289-46ee-a489-94a9f6f9eaf0) [0000950103-24-006573.pdf](/static-files/91552071-5b1c-48a8-bd5c-929ce5f613d5)  \n  \nData provided by [Kaleidoscope](https://www.kscope.io).\n"
        }
      ]
    },
    {
      "section_name": "Annual Reports",
      "links": [
        {
          "title": "Annual Reports",
          "url": "https://ir.acimmune.com/annual-reports",
          "content": "![logo]()\n\n[](https://www.cookiebot.com/en/what-is-behind-powered-by-cookiebot/)\n\n  * [Consent](#)\n  * [Details](#)\n  * [[#IABV2SETTINGS#]](#)\n  * [About](#)\n\n\n\n## This website uses cookies\n\nWe use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. \n\nConsent Selection\n\n**Necessary**\n\n**Preferences**\n\n**Statistics**\n\n**Marketing**\n\n[Show details](#)\n\n  * Necessary  9\n\nNecessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.\n\n    * [Cookiebot2](#)[Learn more about this provider![]()](https://www.cookiebot.com/goto/privacy-policy/ \"Cookiebot's privacy policy\")\n\n**1.gif** Used to count the number of sessions to the website, necessary for optimizing CMP product delivery. \n\n**Maximum Storage Duration** : Session**Type** : Pixel Tracker\n\n**CookieConsent** Stores the user's cookie consent state for the current domain\n\n**Maximum Storage Duration** : 1 year**Type** : HTTP Cookie\n\n    * [Google6](#)[Learn more about this provider![]()](https://business.safety.google/privacy/ \"Google's privacy policy\")\n\nSome of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness.\n\n**_GRECAPTCHA** This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.\n\n**Maximum Storage Duration** : 180 days**Type** : HTTP Cookie\n\n**_grecaptcha** This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**rc::a** This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**rc::b** This cookie is used to distinguish between humans and bots. \n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**rc::c** This cookie is used to distinguish between humans and bots. \n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**rc::f** This cookie is used to distinguish between humans and bots. \n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n    * [chimpstatic.com1](#)\n\n**ak_bmsc** This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.\n\n**Maximum Storage Duration** : 1 day**Type** : HTTP Cookie\n\n  * Preferences  0\n\nPreference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.\n\nWe do not use cookies of this type.\n\n  * Statistics  0\n\nStatistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.\n\nWe do not use cookies of this type.\n\n  * Marketing  21\n\nMarketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.\n\n    * [Google3](#)[Learn more about this provider![]()](https://business.safety.google/privacy/ \"Google's privacy policy\")\n\nSome of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness.\n\n**_ga** Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels.\n\n**Maximum Storage Duration** : 2 years**Type** : HTTP Cookie\n\n**_ga_#** Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels.\n\n**Maximum Storage Duration** : 2 years**Type** : HTTP Cookie\n\n**NID** Pending\n\n**Maximum Storage Duration** : 6 months**Type** : HTTP Cookie\n\n    * [YouTube18](#)[Learn more about this provider![]()](https://business.safety.google/privacy/ \"YouTube's privacy policy\")\n\n**#-#** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**iU5q-!O9@$** Registers a unique ID to keep statistics of what videos from YouTube the user has seen.\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**LAST_RESULT_ENTRY_KEY** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Session**Type** : HTTP Cookie\n\n**LogsDatabaseV2:V#||LogsRequestsStore** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Persistent**Type** : IndexedDB\n\n**remote_sid** Necessary for the implementation and functionality of YouTube video-content on the website. \n\n**Maximum Storage Duration** : Session**Type** : HTTP Cookie\n\n**ServiceWorkerLogsDatabase#SWHealthLog** Necessary for the implementation and functionality of YouTube video-content on the website. \n\n**Maximum Storage Duration** : Persistent**Type** : IndexedDB\n\n**TESTCOOKIESENABLED** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : 1 day**Type** : HTTP Cookie\n\n**VISITOR_INFO1_LIVE** Pending\n\n**Maximum Storage Duration** : 180 days**Type** : HTTP Cookie\n\n**YSC** Pending\n\n**Maximum Storage Duration** : Session**Type** : HTTP Cookie\n\n**ytidb::LAST_RESULT_ENTRY_KEY** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**YtIdbMeta#databases** Used to track user’s interaction with embedded content.\n\n**Maximum Storage Duration** : Persistent**Type** : IndexedDB\n\n**yt-remote-cast-available** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**yt-remote-cast-installed** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**yt-remote-connected-devices** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**yt-remote-device-id** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Persistent**Type** : HTML Local Storage\n\n**yt-remote-fast-check-period** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**yt-remote-session-app** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n**yt-remote-session-name** Stores the user's video player preferences using embedded YouTube video\n\n**Maximum Storage Duration** : Session**Type** : HTML Local Storage\n\n  * Unclassified 0\n\nUnclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.\n\nWe do not use cookies of this type.\n\n\n\n\n[Cross-domain consent2](#) Your consent applies to the following domains:\n\nList of domains your consent applies to:\n\n[ir.acimmune.com](https://ir.acimmune.com)\n[ www.acimmune.com](https://www.acimmune.com)\n\nCookie declaration last updated on 9/17/24 by [Cookiebot](https://www.cookiebot.com \"Cookiebot\")\n\n## [#IABV2_TITLE#]\n\n[#IABV2_BODY_INTRO#]\n\n[#IABV2_BODY_LEGITIMATE_INTEREST_INTRO#]\n\n[#IABV2_BODY_PREFERENCE_INTRO#]\n\n[#IABV2_LABEL_PURPOSES#]\n\n[#IABV2_BODY_PURPOSES_INTRO#]\n\n[#IABV2_BODY_PURPOSES#]\n\n[#IABV2_LABEL_FEATURES#]\n\n[#IABV2_BODY_FEATURES_INTRO#]\n\n[#IABV2_BODY_FEATURES#]\n\n[#IABV2_LABEL_PARTNERS#]\n\n[#IABV2_BODY_PARTNERS_INTRO#]\n\n[#IABV2_BODY_PARTNERS#]\n\nCookies are small text files that can be used by websites to make a user's experience more efficient.The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission.This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.You can at any time change or withdraw your consent from the Cookie Declaration on our website.Learn more about who we are, how you can contact us and how we process personal data in our [Privacy Policy](https://www.acimmune.com/privacy-policy/).Please state your consent ID and date when you contact us regarding your consent.\n\n**Do not sell or share my personal information**\n\nDeny Allow selection Customize Allow all\n\n[Skip to content](#lfg-main-content)\n\n#  Annual Reports \n\n[![2023 Annual Report](/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/assets/2024/03/14/11-14-35/750x1060_AC%20Immune%20AR%202023%20Web%20Ready.png?itok=BNhsrfiq) ](/static-files/0b6263f5-3eb2-4879-8f3a-b3095def936c)\n\nDiscover the 2023 Annual Report\n\n[Read the report](/static-files/0b6263f5-3eb2-4879-8f3a-b3095def936c \"AC Immune AR 2023 Web Ready.pdf\") 4.6 MB\n\nAnnual Reports Archive \n\n[2022 Annual Report](/static-files/de59fd7d-ad7a-407f-8e21-fa3bb682304f \"20230316_AC Immune_Annual Report_2022_final.pdf\") 5.6 MB\n\n[2021 Annual Report](/static-files/d9d1a711-8cbc-4210-898b-45ac286dcf16 \"20220520_Annual_Report_2021_final.pdf\") 1.3 MB\n"
        }
      ]
    }
  ]
}